WP
GOSS icon

Woodline Partners’s Gossamer Bio GOSS Stock Holding History

Woodline Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-495,153
Closed -$1.3M – 1062
2025
Q3 		$1.3M Hold
495,153
– – 0.01% 779
2025
Q2 		$609K Sell
495,153
-233,306
-32% -$254K ﹤0.01% 840
2025
Q1 		$801K Hold
728,459
– – 0.01% 785
2024
Q4 		$659K Sell
728,459
-58,829
-7% -$50.4K ﹤0.01% 806
2024
Q3 		$777K Buy
787,288
+5,510
+0.7% +$5.3K 0.01% 523
2024
Q2 		$704K Buy
781,778
+603,836
+339% +$452K 0.01% 486
2024
Q1 		$210K Buy
+177,942
New +$196K ﹤0.01% 514
2022
Q4 		– Sell
-378,623
Closed -$4.54M – 794
2022
Q3 		$4.54M Sell
378,623
-748,186
-66% -$9.29M 0.06% 312
2022
Q2 		$9.43M Buy
1,126,809
+822,780
+271% +$6.38M 0.15% 185
2022
Q1 		$2.64M Sell
304,029
-673,794
-69% -$6.5M 0.04% 341
2021
Q4 		$11.1M Buy
+977,823
New +$11.6M 0.16% 181

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Woodline Partners's GOSS Position: Q4 2025 in Review

Woodline Partners sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 495,153 shares — an estimated $1.3M sold.

Woodline Partners first reported a position in GOSS in Q4 2021 and held it in 11 quarters. The position peaked at $11.1M in Q4 2021. 195 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • Woodline Partners reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
  • Woodline Partners sold 495,153 Gossamer Bio shares in Q4 2025, an estimated $1.3M.
  • Woodline Partners first reported a position in Gossamer Bio in Q4 2021 and held it in 11 quarters.
  • Woodline Partners's Gossamer Bio position peaked at $11.1M in Q4 2021.
  • 195 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.